The current financial score of Envoy Medical Inc is 5.98. Its financial status is stable, and its operating efficiency is low. Its latest quarterly revenue reached 66.00K, representing a year-over-year increase of 57.14%, while its net profit experienced a year-over-year increase of 32.36%.
The current valuation score of Envoy Medical Inc is 7.73. Its current P/E ratio is -6.59, which is -100.00% below the recent high of 0.00 and -88.09% above the recent low of -12.39.
The current earnings forecast score of Envoy Medical Inc is 8.00. The average price target is 21.67, with a high of 25.00 and a low of 20.00.
The current price momentum score of Envoy Medical Inc is 5.78. Currently, the stock price is trading between the resistance level at 7.89 and the support level at 5.15, making it suitable for range-bound swing trading.
The current institutional shareholding score of Envoy Medical Inc is 3.00. The latest institutional shareholding proportion is 2.42%, representing a quarter-over-quarter decrease of 75.32%.
The current risk assessment score of Envoy Medical Inc is 3.13. The company's beta value is 1.89. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.